Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.14 USD
Change Today +0.01 / 0.88%
Volume 80.9K
ATHX On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for athersys inc (ATHX)

Year over year, Athersys, Inc. has been able to grow their bottom line from a loss of $30.7M USD to a smaller loss of $22.1M USD despite falling revenues.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Reclassified
Dec 31
2012
Reclassified
Dec 31
2013
Reclassified
Dec 31
2014
4 Year
Trend
Revenues10.38.72.41.6
TOTAL REVENUES10.38.72.41.6
Cost of Goods Sold1.419.620.523.4
GROSS PROFIT8.9-10.9-18.0-21.7
Selling General & Admin Expenses, Total5.94.86.16.9
R&D Expenses16.6------
Depreciation & Amortization, Total0.30.30.30.4
OTHER OPERATING EXPENSES, TOTAL22.75.16.47.3
OPERATING INCOME-13.8-16.0-24.5-29.0
Other Non-Operating Income (Expenses)0.01.1-6.36.7
EBT, EXCLUDING UNUSUAL ITEMS-13.8-14.9-30.7-22.3
Gain (Loss) on Sale of Investments0.10.2----
EBT, INCLUDING UNUSUAL ITEMS-13.7-14.7-30.7-22.3
Income Tax Expense-------0.3
Earnings from Continuing Operations-13.7-14.7-30.7-22.1
NET INCOME-13.7-14.7-30.7-22.1
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-13.7-14.7-30.7-22.1
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-13.7-14.7-30.7-22.1
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATHX:US $1.14 USD +0.01

ATHX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Biorestorative Therapies Inc $7.49 USD +0.49
Caladrius Biosciences Inc $1.72 USD -0.015
Cytori Therapeutics Inc $0.36 USD -0.0129
Pluristem Therapeutics Inc $1.89 USD +0.01
StemCells Inc $0.54 USD +0.019
View Industry Companies
 

Industry Analysis

ATHX

Industry Average

Valuation ATHX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 63.5x
Price/Book 4.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 41.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ATHERSYS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.